Early results in the irrational design of new bifunctional chelators

Cancer

Volumn 80, Issue 12 SUPPL., 1997, Pages 2347-2353

  Chang, F ^a   Rusckowski, M ^a   Qu, Timothy ^a   Hnatowich, Donald J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Chelators; Irrational design; Mercaptoacetyltriglycine; Technetium 99m

Indexed keywords

AVIDIN; CHELATING AGENT; CYSTEINE; MERTIATIDE TC 99M; TECHNETIUM 99M;

CHELATION; CONFERENCE PAPER; DIAGNOSTIC VALUE; DRUG PROTEIN BINDING; DRUG PURITY; DRUG STABILITY; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

EID: 0031443407     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19971215)80:12+<2347::aid-cncr3>3.0.co;2-8     Document Type: Conference Paper

References (15)

1. Greer J, Erickson JE, Baldwin JJ, Varney MD. Application of three-dimensional structures of protein target molecules in structure-based drug design. J Med Chem 1994;37:1035-52.
2. Baum RM. Combinatorial approaches provide fresh leads for medicinal chemistry. Chem Eng News 1994;72:20-6.
3. Clackson T, Wells JA. In vitro selection from protein and peptide libraries. Tibtech 1994;12:173-82.
4. 3 for technetium-99m labeling of DNA. Nucl Med Biol. 1997;24:425-32.
5. Fasman GD, editor. CRC Handbook of Biochemistry and Molecular Biology. 3rd edition. Volume 1. Boca Raton, FL: CRC Press, 1976:321.
6. Touchstone JC, Dobbins MF. Practice of thin layer chromatography. New York: Wiley-Interscience Publications, 1978: 210.
7. 3: labeling conditions and quality control. J Nucl Med Technol 1993;21:69-74.
8. 99mTc. J Nucl Med 1995;36:2306-14.
9. 99mTc labeled to antibodies? Nucl Med Biol 1994;21:1035-44.
10. Johannsen B, Syhre R, Spies H, Munze R. Chemical and biological characterization of different Tc complexes of cysteine and cysteine derivatives. J Nucl Med 1978;19:816-24.
11. 99mTc-labeled aminothiols as possible brain perfusion agents. Nucl Med Biol 1988;15:215-23.
12. Eshima D, Taylor A Jr., Fritzberg AR, Kasina S, Hansen L, Sorenson JF. Animal evaluation of technetium-99m triamide mercaptide complexes as potential renal imaging agents. J Nucl Med 1987;28:1180-6.
13. Schneider RF, Subramanian G, Feld TA, et al. N,N′-bis(S-benzoylmercaptoaceamido)ethylenediamine and propylenediamine ligands as renal function imaging agents. I. Alternate synthetic methods. J Nucl Med 1984;25:223-9.
14. 3 and biodistribution of by-products. Appl Radiat Isot 1988;39:121-9.
15. 188Re-labeling of monoclonal antibodies. Cancer 1994;73:769-73.